| Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. | |
| | |
MedLine Citation:
|
PMID: 8962557 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: This study sought to report the long-term result (up to 8 years) of percutaneous transluminal balloon angioplasty (PTBA) for Budd-Chiari syndrome (BCS) caused by membranous obstruction of the inferior vena cava (MOVC). BACKGROUND: We previously reported on this nonoperative form of therapy in a smaller series of patients and found the short-term results to be excellent. METHODS: We studied the long-term results of PTBA in the treatment of BCS caused by MOVC in 42 patients who underwent PTBA with the Inoue balloon catheter between June 1988 and February 1996. There were 28 men and 14 women with a mean age of 35.6 years (range 16 to 56). MOVC was incomplete in 27 patients and complete in 15. PTBA was successful in 38 patients (91%). The longest follow-up period was 8 years. RESULTS: All 38 patients who successfully underwent PTBA showed marked symptomatic improvement. Immediately after PTBA, the diameter of the inferior vena cava at the MOVC increased from 1.7 +/- 2 to 19.9 +/- 3.5 mm (p < 0.0001), the caval pressure below the MOVC decreased from 23.6 +/- 8.5 to 12.0 +/- 6.5 mm Hg (p < 0.0001), and the enlarged liver size decreased from 6.5 +/- 1.5 to 2.0 +/- 1.5 cm below the right costal margin at the midclavicular line (p < 0.0001). Over a follow-up period of up to 8 years (7 to 8 years in 4 patients, 5 to 7 years in 12, 3 to 5 years in 11, 2 to 3 years in 6 and < 2 years in 9), MOVC returned in only 1 patient. This patient, our first, required a second PTBA 3 years later and a third 4.25 years after the second PTBA, in combination with stent placement for recurrence of stenosis. CONCLUSIONS: PTBA with the Inoue balloon catheter is an effective, safe and long-lasting alternative to surgical treatment of patients with BCS due to MOVC. |
| | |
Authors:
|
X L Yang; T O Cheng; C R Chen |
Related Documents
:
|
11491267 - Endovascular stent-grafting in the treatment of superficial femoral artery occlusive di... 2145997 - Recent changes in the treatment of aortoiliac occlusive disease by the oxford regional ... 11951697 - Clinical long-term results of percutaneous transluminal angioplasty in patients with pe... 22982657 - Quality of life evolution after pulmonary metastasectomy: a prospective study comparing... 10842147 - Management of ischemic heel ulceration and gangrene: an evaluation of factors associate... 22640467 - Patient outcomes and thoracic aortic volume and morphologic changes following thoracic ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of the American College of Cardiology Volume: 28 ISSN: 0735-1097 ISO Abbreviation: J. Am. Coll. Cardiol. Publication Date: 1996 Dec |
Date Detail:
|
Created Date: 1997-01-16 Completed Date: 1997-01-16 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8301365 Medline TA: J Am Coll Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1720-4 Citation Subset: AIM; IM |
Affiliation:
|
Chinese People's Liberation Army 150th Central Hospital, Luoyang, Henan, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Angioplasty, Balloon* / instrumentation Budd-Chiari Syndrome / etiology, therapy* Constriction, Pathologic Female Follow-Up Studies Humans Male Middle Aged Vascular Diseases / complications Vena Cava, Inferior / pathology*, radiography |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coronary flow reserve during coronary angioplasty in patients with a recent myocardial infarction: r...
Next Document: Aminophylline reduces cardiac ischemic pain during percutaneous transluminal coronary angioplasty.